急性缺血性卒中静脉溶栓治疗的性别差异:系统综述与荟萃分析
基于17项全卒中患者研究的汇总未调整OR为0.87(95%CI 0.82-0.93),女性接受静脉rtPA治疗的 odds 比男性低13%;在7项符合溶栓条件亚组研究中汇总OR为0.95(95%CI 0.88-1.02),无统计学显著性。对2000至2018年33项研究的时间趋势分析提示性别差异在近年缩小。
要点
- 女性急性缺血性卒中患者接受静脉rtPA治疗的 odds 较男性低13%(汇总未调整OR 0.87,95%CI 0.82-0.93)。
- 在符合溶栓条件的患者亚组中,性别差异未达统计学显著性(汇总OR 0.95,95%CI 0.88-1.02)。
- 2000至2018年研究时间趋势提示静脉溶栓的性别差异在近年缩小。
核心结论
- 汇总近期研究数据显示,女性急性卒中患者接受静脉溶栓治疗的可能性低于男性,但该差异较2008年前发表的研究已缩小。
主要发现
- 基于17项提供全部缺血性卒中患者数据的研究,汇总未调整OR为0.87(95%CI 0.82-0.93),女性接受静脉rtPA治疗的 odds 比男性低13%。
- 在7项提供符合静脉rtPA治疗条件患者亚组数据的研究中,汇总OR为0.95(95%CI 0.88-1.02),无统计学显著性。
- 对2000至2018年发表的33项研究进行时间趋势分析,发现性别差异在近年缩小的证据。
临床怎么用
- 临床中应关注女性急性缺血性卒中患者静脉溶栓治疗机会可能低于男性,注意评估是否存在可纠正的性别相关治疗障碍。
局限性
- 研究间存在相当大的异质性。
- 符合溶栓条件亚组的汇总OR无统计学显著性,提示性别差异可能受研究人群与纳入标准影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A prior meta-analysis of reports published between 2000 and 2008 found that women were 30% less likely to receive IV recombinant tissue plasminogen activator (rtPA) treatment for stroke than men; we updated this meta-analysis to determine if this sex difference persisted. METHODS: We identified studies that reported sex-specific IV rtPA treatment rates for acute ischemic stroke published between 2008 and 2018. Eligible studies included representative populations of patients with ischemic stroke from hospital-based, registry-based, or administrative data. Random effects odds ratios (ORs) were generated to quantify sex differences. RESULTS: Twenty-four eligible studies were identified during this 10-year period. The summary unadjusted OR based on 17 studies with data on all ischemic stroke patients was 0.87 (95% confidence interval [CI], 0.82-0.93), indicating that women had 13% lower odds of receiving IV rtPA treatment than men. However, substantial between-study variability existed. Lower treatment odds in women were also observed in 7 studies that provided data on the subgroup of patients eligible for IV rtPA treatment, although the summary OR of 0.95 (95% CI, 0.88-1.02) was not statistically significant. Examination of time trends across 33 studies published between 2000 and 2018 found evidence that the sex difference had narrowed in more recent years. CONCLUSIONS: Although there is considerable variability in the findings of individual studies, pooled data from recent studies show that women with acute stroke are less likely to be treated with IV thrombolysis compared with men. However, the size of this difference has narrowed compared to studies published before 2008.
引用
- Strong B, Lisabeth LD, Reeves M, et al. Sex differences in IV thrombolysis treatment for acute ischemic stroke: A systematic review and meta-analysis. Neurology. 2020. PMID: 32522796. doi:10.1212/WNL.0000000000009733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。